Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications
D Muthas, A Reznichenko, CA Balendran… - Scandinavian journal …, 2017 - Taylor & Francis
Objectives: This review article describes the role of neutrophils in mucosal injury and the
resulting crypt abscesses characteristic of ulcerative colitis. We also review selected …
resulting crypt abscesses characteristic of ulcerative colitis. We also review selected …
Inflammatory bowel disease therapeutics: A focus on probiotic engineering
J Mishra, M Stubbs, L Kuang, N Vara… - Mediators of …, 2022 - Wiley Online Library
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of gastrointestinal (GI)
tract with dysregulated mucosal immune functions and disturbed commensal ecosystem of …
tract with dysregulated mucosal immune functions and disturbed commensal ecosystem of …
[HTML][HTML] Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
K Dubois-Camacho, PA Ottum… - World journal of …, 2017 - ncbi.nlm.nih.gov
Inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn's disease, are
chronic pathologies associated with a deregulated immune response in the intestinal …
chronic pathologies associated with a deregulated immune response in the intestinal …
[HTML][HTML] Quality of life in inflammatory bowel disease patients: A cross-sectional study
F Habibi, ME Habibi, A Gharavinia… - Journal of Research …, 2017 - journals.lww.com
Background: Inflammatory bowel disease (IBD) has a significant impact on health-related
quality of life (HRQOL). This study aims to investigate the variables which can be attributed …
quality of life (HRQOL). This study aims to investigate the variables which can be attributed …
[HTML][HTML] Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
M Salla, J Guo, H Joshi, M Gordon, H Dooky… - International Journal of …, 2023 - mdpi.com
Persistent inflammation can trigger altered epigenetic, inflammatory, and bioenergetic
states. Inflammatory bowel disease (IBD) is an idiopathic disease characterized by chronic …
states. Inflammatory bowel disease (IBD) is an idiopathic disease characterized by chronic …
Limonene from Agastache mexicana essential oil produces antinociceptive effects, gastrointestinal protection and improves experimental ulcerative colitis
GRA Estrella, GTM Eva, HL Alberto… - Journal of …, 2021 - Elsevier
Ethnopharmacology relevance Agastache mexicana is a popular plant of great demand in
folk medicine, essentially due to its calming properties and for alleviating arthritic, muscular …
folk medicine, essentially due to its calming properties and for alleviating arthritic, muscular …
The underlying inflammatory chronic disease influences infliximab pharmacokinetics
C Passot, D Mulleman, T Bejan-Angoulvant, A Aubourg… - MAbs, 2016 - Taylor & Francis
Infliximab is an anti-tumor necrosis factor monoclonal antibody approved in chronic
inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing …
inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing …
[HTML][HTML] Interaction between the renin–angiotensin system and enteric neurotransmission contributes to colonic dysmotility in the TNBS-induced model of colitis
M Ferreira-Duarte, T Rodrigues-Pinto, T Sousa… - International Journal of …, 2021 - mdpi.com
Angiotensin II (Ang II) regulates colon contraction, acting not only directly on smooth muscle
but also indirectly, interfering with myenteric neuromodulation mediated by the activation of …
but also indirectly, interfering with myenteric neuromodulation mediated by the activation of …
[HTML][HTML] Helminth therapy: advances in the use of parasitic worms against inflammatory bowel diseases and its challenges
M Maruszewska-Cheruiyot, K Donskow-Łysoniewska… - Helminthologia, 2018 - sciendo.com
Development of modern medicine and better living conditions in the 20th century helped in
reducing a number of cases of infectious diseases. During the same time, expansion of …
reducing a number of cases of infectious diseases. During the same time, expansion of …
[HTML][HTML] Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries
HK Yoo, HG Byun, F Caprioli, M Fumery… - BMC Health Services …, 2022 - Springer
Abstract Background In 2020, the European Medicines Agency approved infliximab
subcutaneous (SC) for the treatment of inflammatory bowel disease. This new mode of …
subcutaneous (SC) for the treatment of inflammatory bowel disease. This new mode of …